Related Experiment Videos

Cathepsin L antisense oligonucleotides in a human osteosarcoma cell line: effects on the invasive phenotype

S Krueger1, U Kellner, F Buehling

  • 1Department of Pathology, Otto-von-Guericke University Magdeburg, Leipziger Strasse 44, 39120 Magdeburg, Germany. sabine.krueger@medizin.uni-magdeburg.de

Cancer Gene Therapy
|August 11, 2001
PubMed

Insights

Antisense oligonucleotides targeting cathepsin L (CL) significantly reduced CL expression and inhibited the migration and invasion of human osteosarcoma cells. This suggests CL plays a key role in cancer cell malignancy.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Oncology

Background:

  • Cathepsin L (CL) expression and trafficking are linked to cancer progression and metastasis.
  • Understanding CL's role in osteosarcoma is crucial for developing targeted therapies.

Purpose of the Study:

  • To investigate the impact of cathepsin L antisense oligonucleotides on osteosarcoma cell line MNNG/HOS.
  • To evaluate the effect of reduced CL expression on cellular invasion and migration.

Main Methods:

  • Utilized seven 20-bp antisense phosphorothioate oligonucleotides and one random control to inhibit CL expression.
  • Assessed CL mRNA and protein levels via Northern blot analysis.
  • Evaluated cell adhesion, in vitro motility, and invasion using transwell assays.

Main Results:

  • Six antisense oligonucleotides significantly reduced cathepsin L mRNA and protein expression (50-85%) at 10 microM.
  • Cell adhesion to collagen I and matrigel remained unaffected.
  • Cell migration and invasion through transwell filters were inhibited by 35-75% with antisense oligonucleotides.

Conclusions:

  • Cathepsin L plays a significant role in promoting migration and basement membrane degradation in MNNG/HOS osteosarcoma cells.
  • Targeting cathepsin L expression with antisense oligonucleotides can inhibit the invasive potential of osteosarcoma cells.

Related Concept Videos